Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Meiser

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|November 7, 2008
Design and fabrication of three-dimensional scaffolds for tissue engineering of human heart valvesP K Schaefermeier, D Szymanski, F Weiss, et al.
Transplantation Proceedings|April 1, 1993
Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal modelB M Meiser, K Wenke, J Thiery, et al.
Transplantation Proceedings|December 1, 1993
Pulmonary rejection diagnosis after lung and heart-lung transplantationH Reichenspurner, H Dienemann, M Rihl, et al.
Transplantation Proceedings|June 1, 1995
Prevention and treatment of graft vessel disease after heart transplantationB M Meiser, K Wenke, J Thiery, et al.
The Thoracic and Cardiovascular Surgeon|August 12, 1999
Tacrolimus (FK506) as primary immunosuppressant after lung transplantationF Kur, H Reichenspurner, B M Meiser, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 8, 1999
Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoringB M Meiser, M Pfeiffer, D Schmidt, et al.
Transplantation|February 27, 1994
Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantationB M Meiser, F Kur, H Reichenspurner, et al.
Transplantation Proceedings|March 20, 1999
The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levelsB M Meiser, M Pfeiffer, D Schmidt, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 1, 1997
Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantationB M Meiser, P Uberfuhr, A Fuchs, et al.
Transplantation Proceedings|March 20, 1999
Tacrolimus-based immunosuppressive protocols in lung transplantationH Reichenspurner, F Kur, H Treede, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|November 7, 2008
Design and fabrication of three-dimensional scaffolds for tissue engineering of human heart valvesP K Schaefermeier, D Szymanski, F Weiss, et al.
Transplantation Proceedings|April 1, 1993
Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal modelB M Meiser, K Wenke, J Thiery, et al.
Transplantation Proceedings|December 1, 1993
Pulmonary rejection diagnosis after lung and heart-lung transplantationH Reichenspurner, H Dienemann, M Rihl, et al.
Transplantation Proceedings|June 1, 1995
Prevention and treatment of graft vessel disease after heart transplantationB M Meiser, K Wenke, J Thiery, et al.
The Thoracic and Cardiovascular Surgeon|August 12, 1999
Tacrolimus (FK506) as primary immunosuppressant after lung transplantationF Kur, H Reichenspurner, B M Meiser, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 8, 1999
Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoringB M Meiser, M Pfeiffer, D Schmidt, et al.
Transplantation|February 27, 1994
Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantationB M Meiser, F Kur, H Reichenspurner, et al.
Transplantation Proceedings|March 20, 1999
The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levelsB M Meiser, M Pfeiffer, D Schmidt, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 1, 1997
Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantationB M Meiser, P Uberfuhr, A Fuchs, et al.
Transplantation Proceedings|March 20, 1999
Tacrolimus-based immunosuppressive protocols in lung transplantationH Reichenspurner, F Kur, H Treede, et al.
Pageof 5